This announcement is a separate document:
以岭药业：关于全资子公司制剂产品获得美国FDA批准文号的公告
Eling Pharmaceutical: Notice on Wholly Owned Subsidiary Formulation Products Obtaining U.S. FDA Approval Numbers
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated